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Abstract: Methylglyoxal is a highly reactive α-oxoaldehyde with elevated pro-
duction in hyperglycemia. It reacts with nucleophilic Lys and Arg side-chains 
and N-terminal amino groups causing protein modification. In the present stu-
dy, the importance of the reaction of the Cys thiol group with methylglyoxal in 
protein modification, the competitiveness of this reaction with those of amino 
and guanidine groups, the time course of these reactions and their role and 
contribution to protein cross-linking were investigated. Human and bovine se-
rum albumins were used as model systems. It was found that despite the very 
low levels of thiol groups on the surface of the examined protein molecules 
(approx. 80 times lower than those of amino and guanidino groups), a very 
high percentage of it reacts (25–85 %). The amount of reacted thiol groups and 
the rate of the reaction, the time for the reaction to reach equilibrium, the 
formation of a stable product and the contribution of thiol groups to protein 
cross-linking depend on the methylglyoxal concentration. The product formed 
in the reaction of thiol and an insufficient quantity of methylglyoxal (compared 
to the concentrations of the groups accessible for modification) participates to a 
significant extent (4 %) to protein cross-linking. Metformin applied in equimo-
lar concentration with methylglyoxal prevents its reaction with amino and 
guanidino groups but, however, not with thiol groups. 
Keywords: methylglyoxal; protein thiol group reaction; protein modification 
and cross-linking; AGEs. 
INTRODUCTION 
Advanced glycation end products (AGEs) are elevated in diabetes and are 
involved in the pathogenesis of its vascular complications,1–6 as well as in other 
pathological states. They are formed in the reaction of carbonyl-containing mate-
rials with N-terminal and Lys side-chain amino groups, the guanidino group of 
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Arg, the sulfhydryl group of Cys in proteins, and through a series of reactions 
and rearrangement.7 Some of the final products of these reactions are the well- 
-characterized conjugates (N-(carboxymethyl)lysine, N-(carboxyethyl)lysine, N-(car-
boxymethyl)arginine, S-(carboxymethyl)cysteine, S-(carboxyethyl)cysteine and 
pentosidine), which are used as markers in clinical practice. 
Methylglyoxal (MG) is an α-oxoaldehyde which is formed in cells primarily 
from triose phosphate intermediates of glycolysis, dihydroxyacetone phosphate 
and glyceraldehydes-3-phosphate.8 It is accumulated in hyperglycemia,9,10 oxi-
dative stress, uremia,11 in the aging process and inflammation. As a highly reac-
tive compound (α-dicarbonyl compounds are 20,000-fold more reactive than glu-
cose in glycation reactions12), it participates in the modification of proteins13 and 
DNA14 and leads to the formation of AGEs. Molecules modified with methyl-
glyoxal and their derivatives can affect cellular functionality via gene expres-
sion,15 lead to micro- and macro-vascular complications in diabetes,16 contribute 
to upregulation of inflammatory and tissue-injury-provoking molecules (interact-
tion of AGEs and receptor RAGE), protein cross-linking and apoptosis.17 
Amino, guanidine16 and thiol groups13 present on protein surfaces partici-
pate in protein modification with methylglyoxal. The products formed in the first 
phase of the reaction change in a series of subsequent reactions.18 The thiol 
group is a strong nucleophile, at physiological pH values stronger than the amino 
and guanidine groups of Lys and Arg side chains. Yet, the role of thiol group in 
protein modification with MG has not been sufficiently investigated. The propo-
sed mechanism of reaction of thiol with glyoxal19 or MG13 proved the formation 
of carboxymethylcysteine19–21 and carboxyethylcysteine. These products were 
proposed for use as markers in pathological states19 and attempts were made for 
their quantification.22 The research on Cys side-chain modifications of thiol-de-
pendent enzymes glyceraldehyde-3-phosphate dehydrogenase23 and creatine ki-
nase19 with MG showed their inactivation during incubation. The formation of 
protein aggregates was observed in the treatment of albumin with MG.18 The role 
of amino and thiol groups in cross-linking via reactive compounds, such as glu-
taraldehyde,24 4-hydroxynonenal25 and acrolein26 was stressed. The potential 
importance of SH and MG reaction in protein cross-linking has only been re-
ported by Zeng and Davies.27 They proposed that the product of the initial re-
action between a thiol group and MG can be a target for the next reaction with an 
amino group or, vice versa, the initial product of a reaction between an amino 
group and MG can be a target for an SH group. Since the presence and avail-
ability of thiol groups on the protein surface is marginal compared to amino 
groups, the question is: what is the importance and contribution of the initial 
reaction between SH and MG to cross-linking? What are the target proteins for 
this reaction and what is the physiological role of the formed adducts? 
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Therefore, in this study, the time progression of the reaction of protein thiol 
groups (as well as of amino and guanidino groups) with methylglyoxal, detection 
of protein modifications, the role and contribution of the initial reaction between 
thiol and MG, i.e., the product of that reaction, as a target for protein cross- 
-linking were examined. Also, the effects of inhibitors on the above-mentioned 
reactions, especially during low-dose long-term exposition of albumin to MG, were 
analyzed. Human (HSA) and bovine serum (BSA) albumins were chosen as mo-
del-systems by virtue of the considerably lower thiol group content on the mole-
cule surface compared to amino (and guanidino) group and because of their 
abundance and reported antioxidant properties. 
EXPERIMENTAL 
Materials 
All chemicals were purchased from Sigma, Steinheim, Germany, unless otherwise stated. 
The 20 % solution of HSA was purchased from Octapharma AB, Stockholm, Sweden; thymol, 
3’,3”,5’,5”-tetrabromo-m-cresolsulphonephthalein (BCG), hydroquinone and bromine were 
from Merck, Darmstadt, Germany. 
Preparation of glycated samples 
HSA or BSA solutions (33 mg/mL, i.e., 0.50 mM) were prepared in 0.10 M phosphate 
buffer (pH 7.2) under sterile conditions (sterile zone) and incubated in capped vials at 37 °C 
with different concentrations of MG as follows: BSA with 50 mM MG for 168 h; HSA with 
100 mM MG for 24 h; HSA with 10 mM MG for 24 days. All solutions were sterile-filtered 
prior to incubation. For the investigations of the inhibition of the reactions, glutathione (GSH) 
and metformin (10 and 20 mM) were used. 
Monitoring of changes of HSA and BSA molecules during incubation with MG 
Aliquots of the reaction mixtures were taken at predetermined intervals during incubition 
and subsequently extensively dialyzed against deionized water (3 times within an hour). The 
albumin concentrations after dialysis were assayed by the BCG method.28 Protein changes du-
ring incubation with different methylglyoxal concentrations were monitored using native and 
SDS PAGE. In brief, to 5.0 mL of 0.04 mM BCG in 0.10 M Gly buffer (pH 3.8), 0.02 mL of 
sample was added. The absorbance at 628 nm was measured against the reagent after 30 s. 
Protein changes during the incubation with different MG concentrations were monitored 
using native and SDS PAG (10 % of acrylamide) electrophoresis according to protocol of Ho-
effer scientific instruments.29 7 μL of protein samples (0.05–0.15 mg/mL) were applied. Gels 
were stained by Coomassie Brilliant Blue G-250 (CBB). 
In each aliquot, the contents of the reactive groups were determined in triplicate. 
Thiol assays 
Free thiol groups were assayed spectrophotometrically according to a modified Ellman 
method.30 5,5’-Dithiobis(2-nitrobenzoic acid) reagent (100 μL of 2.0 mM solution) was mixed 
with 10 μL–100 μL of the sample, 100 μL of 1.0 M Tris buffer (pH 8.0) and filled up with 
water to 1300 μL. To avoid interferences of the browning state of modified albumin, the ab-
sorbance was measured at 412 nm against a sample blank, using a Beckman DU 50 spectro-
photometer. In addition, dilution of samples (13–130 times) contributed to the minimization of 
the influences. Standard solutions of 2-mercaptoethanol (0.143–1.43 mM) were used for the 
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construction of a standard curve (y = 0.01013 + 0.7225x; r = 0.9999, p < 0.0001). The SH 
group concentration was also calculated using the extinction coefficient 13600 mol-1 dm3 cm-1. 
As commercially available albumin preparations already contain oxidized Cys34,31 
the content of free thiol group was determined in untreated BSA/HSA (0.73/0.76 mole 
per mole of protein, respectively). The amounts of reacted thiol groups were expressed as 
percentages of these contents. 
Guanidine assay 
A spectrophotometric method32 was used for the determination of guanidino groups. 
To 1.0 mL 0.020 % thymol in 1.0 M NaOH, 10 μL–100 μL sample and 100 μL 2.0 % Br2 
in 5.0 % NaOH were added and the mixture was filled up with water to 2.1 mL. The ab-
sorbance at 470 nm was measured against a reagent blank. A standard curve was prepa-
red with standard arginine solutions in the concentration range 0.125–1.25 mM (standard 
curve: y = – 0.01407 + 0.30933x, r = 0.9992, p < 0.0001). 
Determination of amino groups 
The spectrophotometric determination of amino groups was performed as follows:33 100 
μL sample, 100 μL 1.0 M phosphate buffer (pH 7.2), and 40 μL 0.10 M p-benzoquinone in di-
methyl sulfoxide were mixed and water was added to a volume of 1500 μL. The absorbance at 
480 nm was measured against reagent blank. A standard curve was constructed with alanine in 
the concentration range from 10–90 mM (y = 0.03225 + 0.00695x, r = 0.9966, p < 0.0001). 
Statistical analysis 
Data are expressed as the mean±standard deviation (SD) from a minimum of three expe-
riments. Statistical analysis was performed by the Student’s t-test. 
RESULTS AND DISCUSSION 
BSA and HSA were used as model systems to investigate the role of thiol 
groups in the modification and cross-linking of protein molecules via methyl-
glyoxal. These proteins were chosen due to the fact that the number of amino 
acid side-chains is known, i.e., the number of reactive groups on the protein sur-
face that MG can react with,18,34 and the number of thiol groups (only one) is con-
siderably lower compared to the number of Lys (59) and Arg (24) side-chains. 
Considering the higher reactivity of the SH-group compared to the amino and 
guanidine groups at physiological pH values and the substantially lower avai-
lability for reaction, it was of interest to investigate the importance of this reac-
tion for protein modification at different MG concentrations. On the other hand, 
the abundance of HSA in the serum may point to its additional role in carbonyl 
stress. 
Modification of BSA in reaction with methylglyoxal 
A reaction mixture of BSA (0.50 mM) and methylglyoxal (50 mM) in 0.10 
M phosphate buffer (pH 7.2) was incubated for 7 days at 37 °C. A considerably 
higher concentration of MG than the physiological one (free MG in plasma is < 5 
µM35 with > 90 % MG bound to proteins13) was used in order to monitor and 
compare the reaction rates of each group (thiol, amino and guanidino) accessible 
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for modification. In addition, the employed MG concentration was higher (by 19 
%) than the sum of reactive groups per mole of BSA surface of the protein mole-
cule. BSA modification was monitored over time by native and SDS PAGE 
(Figs. 1A and 1B, respectively). 
A considerable change in the mobility of BSA during native electrophoresis, 
i.e., a decrease in the positive charge of the protein, was observed after 2 and 4 h 
of incubation (Fig. 1A, lanes 2 and 4, respectively). The mobility of the protein 
band increased with incubation time. A broadening and higher diffuseness of the 
protein bands during native and SDS PAGE was detected as early as after 4–6 h 
of incubation, which continued as the incubation proceeded further. These bands 
tailed to higher molecular mass values in the period from 1 to 7 days of incubation. 
      
Fig. 1. Native (A) and SDS-PAGE (B) showing the changes of BSA electrophoretic mobility 
resulting from reaction with methylglyoxal. BSA (0.50 mM) was treated with 50 mM MG in 
0.10 M phosphate buffer (pH 7.2) at 37 °C for 7 days. Lane c shows nontreated BSA. The 
marks of other lines correspond to time of incubation (h) of BSA with MG. The 
electrophoresis was performed on 10 % polyacrylamide gels and the bands 
were visualized by CBB, as detailed in the Experimental. 
Comparison of the reactivity of the thiol, amino and guanidine groups of the BSA 
amino acid side chains with methylglyoxal 
In order to determine the role and contribution of the thiol groups and to 
compare them with the contributions of the amino and guanidino groups to the 
changes in BSA as observed in the electrophoregrams, the progress of reactions 
of these groups with MG was monitored by their quantification in aliquots of the 
reaction mixture during incubation (Fig. 2). 
The changes in the amounts, i.e., the percentages, of reacted guanidino and 
thiol groups in the reaction mixture after 7 days were very similar. After 24-hour 
incubation, 66 % of the arginine side chains, 53 % of the thiol groups and only 21 % 
of the amino groups had reacted. In the following two days of incubation, the 
percentage of the reacted guanidino groups rose to 81 % and of thiol to 77 %, at 
which levels they remained until the end of incubation (7 days). The content of 
amino groups changed moderately from the first to the seventh day of incubation 
(24.8±2.4 %). 
2009 Copyright (CC) SCS
_______________________________________________________________________________________________________________________________________________
Available online at www.shd.org.rs/JSCS
872 AĆIMOVIĆ, STANIMIROVIĆ and MANDIĆ 
Fig. 2. Quantification of thiol, 
amino and guanidino groups (% 
of the ones reacted) during the in-
cubation of 0.50 mM BSA with 
50 mM MG in 0.10 M phosphate 
buffer (pH 7.2) at 37 °C for 7 
days. Data are the means from 
three determinations. SD data for 
particular reactive group and spe-
cific time points are presented in 
Table I. 
It is of interest to compare the changes in the contents of the reactive groups 
during the first 8 h of reaction, the period when modification of the protein mo-
lecules was detected by electrophoresis. The amount of guanidino groups de-
creased by 26 % in the first 2 h of incubation and had decreased by 37 % after 4 
h. In the same time period, the amount of thiol groups decreased by 20 and 30 %, 
respectively. After 8 h, under the employed incubation conditions, only about 8 % 
of amino groups had reacted. 
The contribution of the reaction of individual reactive groups to the changes 
of the BSA molecules observed by electrophoresis can be better realized if the 
percentages of the reactive groups are converted to the corresponding number of 
amino acid side-chains (mole) reacted per molecule (mole) of BSA (Table I). 
After a three-day incubation (the equilibrium state), the total content of amino 
acid side-chains reacted per BSA molecule was 36 (43.1 %).The contribution of 
MG reaction with guanidino groups to the decrease of the positive charge of BSA 
was higher compared to the contribution of the amino groups. The percentage of 
modified thiol groups to the total content of modified amino acid residues (1.55 %) 
was almost two times higher than that in untreated BSA (0.87 %). Modification 
of the SH groups can contribute to a broadening of protein bands in electropho-
resis. The increased broadening of the protein bands with time reflects the pro-
duction of multiple modified forms of the protein (modification with different 
numbers of MG molecules and different sites). 
Some previous studies36 showed that a decrease in the free thiol content in 
BSA could be the result of an oxidation process rather than of the glycation pro-
cess with MG. For this reason, the potential oxidation of thiol group in BSA due 
to influence of temperature (37 °C) and the presence of oxygen in the solutions 
was followed by determining of the –SH content in untreated albumin (control). 
During the incubation, the content of –SH groups changed insignificantly. After 
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168 h, it had decreased by only 8 %. Since in the first hours of BSA incubation 
with MG, the registered decrease of free SH groups was by 20–30 % (Table I), 
this is mainly the result of the glycation reaction. According to the proposed me-
chanism,7,13 thiohemiacetal is formed in the reaction of SH group and MG, which 
is converted by a Cannizzaro-type rearrangement into (1-carboxyethyl)cysteine 
or participates in the cross-linking of protein molecules.27 
TABLE I. Content of reacted amino acid side-chains. BSA (0.50 mM) was treated with 50 
mM MG in 0.10 M phosphate buffer (pH 7.2) at 37 °C for various time periods 
Incubation time, h Reacted groups (mol/mol of BSA) %a 
Thiol Amino Guanidino Total 
2 0.149±0.010 0.66±0.12 6.29±0.15 7.10 8.50 
4 0.220±0.012 3.25±0.15 8.91±0.39 12.36 14.8 
8 0.247±0.001 4.72±0.32 9.64±0.15 15.77 18.9 
24 0.390±0.007 12.59±1.15 15.93±0.15 28.91 34.5 
48 0.468±0.011 13.96±0.92 15.86±1.08 30.29 36.2 
72 0.564±0.014 15.98±1.15 19.51±0.77 36.05 43.1 
168 0.677±0.009 16.36±1.01 20.25±0.77 37.28 44.5 
aTotal reacted groups as the percent of the total number of available groups 
Inhibition of methylglyoxal-induced modifications of BSA by GSH and metformin 
The experiment of BSA (0.50 mM) incubation with MG (50 mM) was also 
performed in the presence of glutathione (GSH) and metformin as inhibitors of 
MG reaction with amino acid side chains. The experiments were performed 
separately; the concentration of the inhibitors was 20 mM (2.5 times lower com-
pared to the MG concentration). The results of monitoring BSA modification by 
native and SDS electrophoresis in the presence of GSH and metformin are shown 
in Fig. 3. 
Changes in BSA mobility in native electrophoresis were observed in the pre-
sence of both inhibitors (Fig. 3A) but to a smaller extent in the presence of met-
formin (lanes 3, 6, and 9). Relative electrophoretic migration (REM) was deter-
mined by calculating the ratio of migration of modified BSA with nontreated al-
bumin (Table II). Significant decreases in REM were found for BSA modified in 
presence of metformin compared to BSA-MG and BSA-MG + GSH after four (p < 
< 0.01 for both) and eight (p < 0.001; p < 0.05, resp.) hours of incubation. These 
results are consistent with the findings which underlined metformin as potent 
glycation inhibitor.37,38 On the other hand, in the presence of GSH, significant 
decrease of REM (p < 0.001 vs. BSA-MG) was found only after eight hours of 
incubation. Thus, positive charge of BSA molecules in presence of metformin is 
higher than in presence of GSH. A broadening of MG modified BSA (BSA-MG) 
bands in SDS PAGE was also found in the presence of both inhibitors after only 
4 hours of incubation (Fig. 3B), but to a smaller extent in the presence of GSH 
(lanes 2, 5, 8) compared to the system with metformin (lanes 3, 6, 9) and without 
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inhibitor (lanes 1, 4, 7) for the same period of time. These findings confirm the 
importance of –SH reaction with MG in protein modification as well as the role 
of compounds that contain reactive thiol group as competitive inhibitor of gly-
cation. The obtained results are in agreement with the established depletion of se-
rum thiol levels and erythrocytic GSH in diabetics compared to healthy indivi-
duals.39,40 
Fig. 3. Native (A) and SDS- 
-PAGE (B) showing the changes 
of BSA (0.50 mM) resulting 
from the reaction with MG (50 
mM) in the presence (20 mM) 
and absence of GSH and met-
formin. The incubation was per-
formed in 0.10 M phosphate buf-
fer (pH 7.2) at 37 °C for 7 days. 
The marks of the lanes: lane c – 
– untreated BSA; lanes 1, 4 and 
7 – BSA+MG; lanes 2, 5 and 
8 – BSA+MG+GSH; lanes 3, 6 
and 9 – BSA+MG+metformin. 
The electrophoresis was perfor-
med on 10 % polyacrylamide gels 
and the bands were visualized 
with CBB, as detailed in the Ex-
perimental. 
TABLE II. Relative electrophoretic migrations (REM) of BSA modified with MG (BSA-MG) 
and in the presence of inhibitors (BSA-MG + GSH; BSA-MG + metformin). Data of REM are 
presented as mean±SD (n = 3) and statistical analyses were performed using the t-test 
Time, h REM 
BSA-MG BSA-MG + GSH BSA-MG + metformin 
0.5 1.044±0.007 1.055±0.027 1.043±0.008 
4 1.222±0.007 1.220±0.008 1.186±0.009a 
8 1.347±0.011 1.259±0.013b 1.222±0.012c,d 
ap < 0.01 compared with BSA-MG and BSA-MG + GSH; b,cp < 0.001, compared with BSA-MG; dp < 0.05, 
compared with BSA-MG + GSH 
HSA modification in the reaction with methylglyoxal 
The investigation of BSA modification with a small excess (19 %) of MG 
compared to the total amount of reactive groups (8418) showed a significant re-
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duction in the content of thiol groups and did not give cross-linking of the protein 
molecules. The obtained results were the basis for design of the experiments (re-
garding the MG concentration and duration of incubation) for the examination of 
HSA changes with MG. In order to determine the dependence of modification of 
the amino acids of the protein side chains on the MG concentration, HSA was in-
cubated in the presence of an excess or shortage of MG compared to the total 
amount of reactive groups on the protein surface. 
First, HSA (0.50 mM) was incubated with MG at a concentration (100 mM), 
considerably higher than the physiological concentration35 and higher than the 
total amount of reactive groups on the protein surface18. The reaction mixture in 
0.10 M phosphate buffer pH 7.2 was incubated at 37 °C for 24 h because after 
this time, intensive modification of protein molecules was detected in the expe-
riment with BSA. The progress of MG reaction with thiol, amino and guanidino 
group of HSA was monitored by measuring levels of these groups in aliquots of 
the reaction mixture with time. 
The reaction rate of the guanidine group was the highest: 48 % of available 
groups reacted during the first 30 min of the reaction, after which it remained un-
changed (48.6±3.9 %) during the next 10 h of reaction. In the first 30 min, only 
20 % of the available amino groups had reacted and after 4 h the percentage had 
doubled, after which time there was a gradual increase (to 49 %) after up to 10 h 
of incubation. The data for the progress of SH-group reaction indicates that 30 % 
of the groups had reacted after 30 min, 55 % after 2 h and 65 % after 10 h. At the 
end of the incubation period (24 h), approx. 70 % of the amino and guanidine 
groups and 85 % of the SH-groups had reacted. 
HSA modification under these conditions was also monitored by native and 
SDS PAGE (Fig. 4). Changes in the charge of HSA were detected by native elec-
trophoresis after 15 min of incubation (Fig. 4A). During 24 h of incubation, the 
positive charge of HSA continually declined. The changes in the charge of the 
HSA molecules are consistent with the change in the amounts of reacted 
guanidino and amino groups per HSA molecule (Table III). They were the most 
pronounced during the first two hours of incubation (maximum percentage of 
guanidino and a significant percentage of amino groups had reacted). The 
contribution of MG reaction with the amino groups to the change of the HSA 
charge increased with time. 
SDS PAGE analysis (Fig. 4B) of MG modified HSA (MG-HSA) showed 
marked changes from unmodified HSA: there was a broadening of the peak of 
molecular mass 66 kDa corresponding to MG-HSA monomers. This band tailed 
to higher molecular mass values (extending to 90 kDa) after a very short time of 
incubation (about 30 min) and became more intensive with time. Also, the pre-
sence of dimers (of molecular mass ca. 130 kDa) and oligomers was found. 
These findings indicate intensive fragmentation and cross-linking of fragments (a 
broad band ranging between molecular masses 48–90 kDa), as well as HSA cross- 
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-linking under the employed incubation conditions during this period of time. 
Taking into account that: 
– the percentage of reacted guanidino groups was the highest during the first 
30 min and did not change during further incubation, 
– oligomers were easily detected during SDS-PAGE after two hours of incu-
bation, during which time the amount of reacted amino and SH-groups increased 
(Table III) and 
– the cross-linking of proteins increased with time (and the amounts of free 
amino and SH-groups decreased), 
it can be concluded that lysine and cysteine residues play a more important role 
in the cross-linking of protein molecules than those of arginine. 
Lysine side chains participate in HSA cross-linking via MG-SH (hemithio-
acetal) or MG-NH2 products formed during the first step, which is consistent 
with an earlier proposal.27 The obtained results are also in agreement with the 
proposed mechanism of MG reaction with the guanidino group,13 in which the 
product of the first step participates in an intramolecular reaction with the guani-
dino residues of arginine, forming an imidazolone derivative, thus preventing any 
further linking. 
 
 
Fig. 4. Native (A) and SDS-PAGE (B) showing the changes in the mobility of HSA resulting 
from the reaction with MG. HSA (0.50 mM) was treated with 100 mM MG in 0.10 M phos-
phate buffer (pH 7.2) at 37 °C for 24 h. Lane c shows untreated HSA. The marks of other 
lanes correspond to the time incubation (h) of BSA with MG. Lane m – high-molecular 
mass standards (34, 48, 86 and 120 kDa). The electrophoresis was performed on 10 % poly-
acrylamide gels and the bands were visualized with CBB, as detailed in the Experimental. 
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TABLE III. Content of reacted amino acid side-chains. HSA (0.50 mM) was treated with 100 
mM MG in 0.10 M phosphate buffer (pH 7.2) at 37 °C for various time periods 
Incubation time, h 
Reacted group (mol/mol of HSA) 
%a 
Thiol Amino Guanidino Total 
0.5 0.222±0.009 11.80±0.52 11.52±0.35 23.54 28.10 
2  0.413±0.009 18.90±0.38 10.15±0.17 29.46 35.17 
4  0.417±0.004 24.06±0.61 11.80±0.52 36.27 43.31 
8  0.459±0.013 25.28±0.52 10.96±0.43 36.70 43.81 
10  0.495±0.006 28.91±0.46 11.93±0.40 41.34 49.35 
24  0.647±0.004 40.71±0.48 16.8±0.33 58.16 69.43 
atotal reacted groups as the percent of the total number of available groups 
Comparison of results obtained for modified BSA and HSA (Tables I and III) 
indicate that the total amount of reacted amino acid side-chains per mole of HSA, 
after 24 h of incubation, was two times higher than per mole of BSA (58.16 vs. 
28.91). It could be said that this result conforms to the fact that the concentration 
of MGO in reaction mixtures with HSA was two times higher. During the entire 
incubation period, the amounts of reacted –SH groups were also approximately 
two times higher in HSA compared to BSA. The amounts of reacted Arg residues 
in HSA and BSA were similar after 8 and 24 h of incubation. However, it is noti-
ceable that during the entire incubation period, the contribution of the reaction of 
MG with amino groups to the modification of HSA was several times higher 
compared to BSA. Changes in the content of amino groups brought about differ-
ences in electrophorisograms of the modified HSA compared to those obtained 
for BSA. 
The HSA modifications and the contributions of the amino acid side chains 
to the changes described above result from HSA incubation with an amount of 
MG (200 mmol/mol HSA) that was considerably higher than the sum of the avai-
lable groups (8418). However, it was important not only to determine the role, 
contributions and reactivity of each type of group (–SH, amino and guanidino) in 
protein modification when the amount of MG was lower than the sum of the 
available groups, but also to monitor changes over a longer period of time. There-
fore, HSA (0.50 mM) was incubated with 10 mM MG in 0.10 mM phosphate 
buffer (pH 7.2) at 37 °C for 24 days. The chosen MG concentration was 10 times 
lower than the concentration used in the previous HSA incubation experiment 
and approx. 4 times lower than the sum of amino, guanidino and SH-groups on 
the surface of the protein molecule. 
The changes in the amount (mol) of the thiol, amino and guanidino groups 
per mole of HSA during 24 days are shown in Table IV. In the case of MG re-
action with guanidino and amino group, equilibrium was achieved after one day 
of incubation, with approx. 50 % (47.2±3.8 %) of the guanidino and 35 % of the 
amino groups reacted. Also, HSA mobility during native electrophoresis changed 
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considerably after the first day of incubation (Fig. 5A, lane 1), and changed 
slightly in the following days (lanes 2–8); differences between REM values ob-
tained for those bands are not significant). Due to the high reaction rate of MG 
with the guanidino group, the percentages of Arg residues reacted during 24 h 
both in the case of insufficient and excess amount of MG were very high (50 and 
70 %, respectively, Table V). This indicates a similar contribution of this reaction 
to the change in the HSA charge at different MG concentrations. The difference 
in the percentage of reacted amino groups at both shortage and excess of MG was 
more significant (35 and 69 %, respectively). Yet, the contribution of the reaction 
of the amino groups to the change of the HSA charge even at insufficient amount 
of MG was very high. After 24 h of incubation, 20.7 mol of Lys residues per 
mole of HSA had reacted (Table IV), which makes approx. 63 % of the total 
number of modified amino acid residues. 
TABLE IV. Content of reacted amino acid side-chains. HSA (0.50 mM) was treated with 10 
mM MG in 0.10 M phosphate buffer (pH 7.2) at 37 °C for 24 days 
Incubation time, days 
Reacted group (mol/mol of HSA) 
%a 
Thiol Amino Guanidino Total 
1 0.198±0.009 20.75±0.70 11.97±0.08 32.92 39.3 
3 0.430±0.006 20.39±0.83 10.40±0.23 31.22 37.3 
5 0.494±0.003 23.69±0.96 11.51±0.39 35.69 42.6 
7 0.528±0.012 24.08±1.11 12.22±0.23 36.83 44.0 
9 0.509±0.015 28.70±0.42 13.20±0.08 42.40 50.6 
15 0.514±0.010 27.45±0.14 10.85±0.23 38.81 46.3 
24 0.550±0.008 29.13±0.36 10.51±0.20 40.19 48.0 
atotal reacted groups as the percent of the total number of available groups 
The broadening of the HSA bands in SDS PAGE with tails to higher mole-
cular mass values (Fig. 5B, lanes 3 and 5, obtained after 3 and 5 days of incuba-
tion) points to cross-linking of the protein molecules even with an insufficient 
amount of MG. The high content of reacted amino groups (compared to the MG 
concentration, 20 mM) as early as after 24 h of incubation points to their role in 
the cross-linking. Over a longer incubation period (from 9–24 days), fragmenta-
tion also emerges (the occurrence of bands with lower molecular mass values, 
lanes 9 and 24, Fig. 5B). Zeng and Davies27 suggested that the initial addition of 
the thiol to the dicarbonyl compound and subsequent reaction with an amine can 
lead to cross-link formation. It could be asked what is the contribution of the SH-
-groups in the formation of aggregates under conditions of an insufficient amount 
of MG, since the number of SH-groups on the surface of the HSA molecule is 
negligible compared to the number of amino and guanidino groups (1:59:24).18 
After the first day of HSA incubation with 10 mM MG, 26 % of the SH-groups 
had reacted (0.198 mol/mol HSA), 51 % after the second day (0.388 mol/mol 
HSA) and equilibrium was achieved after 5 days when 65 % of the groups had 
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reacted (0.494 mol per mole HSA) (Table III). During this period, bands with 
expressed tailing to higher molecular mass values were obtained during SDS 
PAGE. In addition, a slight increase of reacted amino groups was found (from 35 
to 40 %), which indicates the possibility of reaction with the hemithioacetal and 
the role of SH-group in protein modification and cross-linking. Taking into ac-
count the MG concentration (10 mM) in reaction mixture, the HSA concentration 
(0.50 mM), the number of reactive groups on the protein surface, the amount of 
reacted amino (40 %) and guanidino (50 %) groups, it can be concluded that 8.0 
mM amino groups participated in cross-linking after 5 days of incubation under 
these conditions. Based on the amount of reacted SH-groups (65 %), i.e., hemithio-
acetals formed during 5 days of incubation, it could be concluded that approx. 4 % 
of the cross-linking of the protein molecules was a consequence of hemithioace-
tal reaction with an amino group. This percentage is not negligible taking into 
account the extremely low distribution of SH-groups on the protein surface com-
pared to amino and guanidino groups. 
 
 
Fig. 5. Native (A) and SDS-PAGE (B) showing the changes of the mobility of HSA (0.50 
mM) resulting from the reaction with methylglyoxal (10 mM). The incubation was performed 
in 0.10 M phosphate buffer (pH 7.2) at 37 °C for 24 days, with (10 mM) and without 
metformin. Lane c shows HSA without metformin and lanes 2–24 with MG. The number 
of the lane corresponds to the number of incubation days. The label i beside the lane 
number shows that the incubation was performed in the presence of metformin. The 
electrophoresis was performed on 10 % polyacrylamide gels and the bands 
were visualized with CBB, as detailed in the Experimental. 
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TABLE V. Dependence of the levels of reacted thiol, amino and guanidino groups of HSA 
(%) on the MG concentration and incubation time. The concentration of HSA was 0.50 mM 
Group 
MG concentration, mM 
100 10 
Incubation time 
30 min 2 h 10 h 1 day 1 day 2 days 5 days 
Thiol 30 55 65 85 26 51 65 
Amino 20 34 49 69 35 35 40 
Guanidino 48 No change 70 50 No change 
The modification of albumin through glycation and the subsequent formation 
of AGEs have been shown to contribute to vascular complications in patients 
with diabetes. Some studies have focused on the changes of its antioxidant pro-
perties36,41–43 and role of the thiol group (Cys 34) in these changes. Faure43 
suggested that MG can strongly impair the structure and antioxidant properties of 
albumin in vitro, leading to a modified protein similar to that isolated from dia-
betic patients. The results of the quantification of the reactive groups and parallel 
electrophoretic monitoring of HSA changes, especially at low-dose long-term ex-
position of albumin to MG (obtained in this paper) showed that the –SH group, in 
addition to the amino group, plays a role in the modification of proteins with MG 
and cross-linking. The significant decrease of the content of –SH groups by 26 % 
after 1 h incubation, i.e., 72 % after 24 h of incubation, in the presence of MG 
may have as a consequence a decrease of the anti-oxidative capacity of albumin, 
which is consistent with the results of Faure et al.43 
To investigate the influence of inhibitor on low-dose long-term exposition of 
HSA to MG, metformin was chosen. It was found that oxidative stress and glyca-
tion were significantly lower in metformin-treated patients with Type 2 diabetes 
mellitus.38 In addition, experiments with BSA showed that the change of the po-
sitive charge of the BSA molecule was lower in the presence of metformin than 
in the presence of GSH. 
The inhibitor metformin in an equimolar concentration with MG (during 
low-dose long-term exposition of albumin to MG), under conditions of an insuf-
ficient amount of MG, decreased the amounts of amino and guanidino groups 
that reacted in the first day by two to three times compared to the system without 
inhibitor. After a 24-h incubation, 15 % of the guanidino groups, (3.6 mol Arg 
residues per mole of HSA), approx. 8 % of the amino (4.7 moles of Lys side- 
-chain per mole of HSA) and 86 % of the –SH groups (0.653 mol Cys thiol per 
mole of HSA) had reacted (Fig. 6). The obtained results are in agreement with 
the smaller changes in HSA mobility (protein charge) during native electrophore-
sis in the presence of metformin (Fig. 5A, lanes 1i, 2i, 4i, 5i, 7i and 8i) compared 
to the bands obtained without this inhibitor. Relative electrophoretic mobilities 
obtained for HSA bands in the presence of metformin were significantly lower 
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(p < 0.001 for 1i to 7i and p < 0.01 for 8i) compared to the same ones without 
inhibitors. However, in the presence of this inhibitor, a broadening of the bands 
with tails to higher molecular mass values was recorded in SDS PAGE (Fig. 5B). 
Since all thiol groups reacted under these conditions, the product of reaction bet-
ween SH-group and MG is the target for the Lys side-chain amino groups in pro-
tein cross-linking. 
Fig. 6. Quantification of thiol, ami-
no and guanidino groups (% of the 
ones reacted) during the incu-
bation of 0.50 mM HSA with 10 
mM methylglyoxal in the presence 
of metformin (10 mM), in 0.10 M 
phosphate buffer (pH 7.2) at 37 °C 
for 24 days. The data are the means 
from three determinations. 
In hyperglycemia, the glycation process is accompanied by an oxidation pro-
cess. By applying metformin as an antihyperglycemic agent in patients with Type 
2 diabetes mellitus, the oxidation of the albumin thiol group was decreased.38 
Metformin decreases the content of toxic dicarbonyl and thereby inhibits the de-
velopment of AGEs. In the present study, at the equimolar concentration of MG 
and metformin almost all the –SH groups reacted. This indicates that in the 
mixture where MG is the only reactive species, the glycation reaction of the albu-
min thiol group is proceeding. 
An absence of fragments of lower molecular mass value (formed during 9– 
–24 days of incubation, lanes 9 and 24, Fig. 5B) in the presence of metformin 
(Fig. 5B, lanes 13i, 15i, 17i, 19i, 21i, 24i), indicates the role of the reaction of 
guanidine with MG in the unfolding and fragmentation of the protein. 
CONCLUSIONS 
The results obtained indicate that thiol group reaction, despite the very small 
presence of thiol groups on the surface of the protein molecule, (80 times less 
available compared to amino and guanidino groups in HSA18) plays an important 
role in protein modification with MG and in cross-linking. Since these changes in 
proteins can be a cause of the development of secondary complications in dia-
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betes,16 modification of signal transduction15,44 and the cause of various patho-
logical states,17 the application of MG scavenger substances is of importance in 
clinical practice. To date, various inhibitors of MG reactions with thiol, amino 
and guanidino groups have been tested, providing differences in their inhibition 
potency. The results presented in this paper show that metformin at equimolar 
concentration with MG inhibits its reaction with guanidino group but not, how-
ever, with the thiol group. 
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И З В О Д  
УЛОГА ТИОЛНЕ ГРУПЕ У МОДИФИКАЦИЈИ ПРОТЕИНА СА МЕТИЛГЛИОКСАЛОМ 
ЈЕЛЕНА М. АЋИМОВИЋ, БОЈАНА Д. СТАНИМИРОВИЋ и ЉУБА М. МАНДИЋ 
Hemijski fakultet, Univerzitet u Beogradu, p.pr. 51, 11158 Beograd 
Метилглиоксал је веома реактивни α-оксоалдехид који се повећано ствара у хипергли-
кемији. Реагује са нуклеофилним групама бочних остатака Lys, Arg и N-терминалном амино-
-групом, што доводи до модификације протеина. У овом раду испитивани су значај реакције 
SH групе са метилглиоксалом у модификацији протеина, конкурентност ове реакције у од-
носу на реакције са амино- и гванидино-групом, ток ових реакција и њихова улога и допри-
нос у умрежавању протеина. Као модел-системи употребљени су хумани и говеђи серум-ал-
бумин. Утврђено је да и поред веома мале заступљености SH групе на површини испити-
ваних молекула протеина (око 80 пута мања у односу на укупан број амино- и гванидино- 
-група), она реагује у великом проценту (од 25–85 %). Количина изреагованих SH група и 
брзина реакције, време успостављања равнотеже реакције, стварања стабилног произавода и 
допринос SH група умрежавању протеина зависе од концентрације метилглиоксала. Про-
извод створен у реакцији SH група и недовољне количине метилглиоксала (у односу на кон-
центрацију група доступних за модификацију) учествује у умрежавању протеина са значај-
ним уделом (4 %). У еквимоларној концентрацији са метилглиоксалом метформин спречава 
његову реакцију са амино и гуанидино групама албумина, али не и са тиол групом. 
(Примљено 26. новембра 2008, ревидирано 9. фебруара 2009) 
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